Prioritize validation over discovery of novel antibiotics
Open Access
- 28 October 2026
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 123 (44)
Abstract
Prioritize validation over discovery of novel antibioticsFunding Information
- Wellcome Trust (227559/Z/23/Z)
This publication has 16 references indexed in Scilit:
- AI cannot replace human participants in behavioral researchProceedings of the National Academy of Sciences, 2026
- A new family of rolling-circle replication endonucleases widespread in archaeal viruses and plasmidsNucleic Acids Research, 2026
- A Synthetic Phage-Peptide Conjugate as a Potent Antibacterial Agent for Pseudomonas aeruginosa InfectionsACS Central Science, 2025
- Emerging roles of antimicrobial peptides in innate immunity, neuronal function, and neurodegenerationTrends in Neurosciences, 2024
- Mining human microbiomes reveals an untapped source of peptide antibioticsCell, 2024
- Ribonuclease 4 functions as an intestinal antimicrobial protein to maintain gut microbiota and metabolite homeostasisNature Communications, 2024
- Deep-learning-enabled antibiotic discovery through molecular de-extinctionNature Biomedical Engineering, 2024
- Gene Therapy in a Patient with Sickle Cell DiseaseNew England Journal of Medicine, 2017
- Convergent Balancing Selection on an Antimicrobial Peptide in DrosophilaCurrent Biology, 2016
- The big and small of drug discoveryEMBO Reports, 2003